Total prostatectomy within 6 weeks of a prostate biopsy

Is it safe?

Kishore T. Adiyat, Murugesan Manoharan, Devendar Katkoori, Ahmed Eldefrawy, Mark S. Soloway

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Purpose: Many urologists recommend a six-week time interval between a prostate biopsy and a total prostatectomy (TP) to allow the biopsy induced inflammation to subside. Our aim was to assess whether the time interval between prostate biopsy and TP has an impact on the surgical outcome. Materials and Methods: A retrospective analysis was performed on data from patients who underwent a TP by a single surgeon from 1992 to 2008. The patients were divided into two groups according to the time interval between biopsy and TP, Group 1 ≤ 6 weeks and Group 2 > 6 weeks. Relevant perioperative variables and outcome were analyzed. Results: 923 patients were included. There was a significant difference between the two groups in the surgeons' ability to perform a bilateral nerve sparing procedure. Those who had a TP within six weeks of the biopsy were less likely to have a bilateral nerve sparing procedure. No significant difference was noted in the other variables, which included Gleason score, surgical margin status, estimated blood loss, post-operative infection, incontinence, erectile function, and biochemical recurrence. Conclusions: TP can be safely performed without any increase in complications within 6 weeks of a prostate biopsy. However, a TP within six weeks of a biopsy significantly reduced the surgeon's perception of whether a bilateral nerve sparing procedure was performed.

Original languageEnglish
Pages (from-to)177-181
Number of pages5
JournalInternational Braz J Urol
Volume36
Issue number2
DOIs
StatePublished - Mar 1 2010

Fingerprint

Prostatectomy
Prostate
Biopsy
Aptitude
Neoplasm Grading
Inflammation
Recurrence
Infection
Surgeons

Keywords

  • Biopsy
  • Outcomes
  • Prostatectomy
  • Prostatic neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Adiyat, K. T., Manoharan, M., Katkoori, D., Eldefrawy, A., & Soloway, M. S. (2010). Total prostatectomy within 6 weeks of a prostate biopsy: Is it safe? International Braz J Urol, 36(2), 177-181. https://doi.org/10.1590/S1677-55382010000200007

Total prostatectomy within 6 weeks of a prostate biopsy : Is it safe? / Adiyat, Kishore T.; Manoharan, Murugesan; Katkoori, Devendar; Eldefrawy, Ahmed; Soloway, Mark S.

In: International Braz J Urol, Vol. 36, No. 2, 01.03.2010, p. 177-181.

Research output: Contribution to journalArticle

Adiyat, KT, Manoharan, M, Katkoori, D, Eldefrawy, A & Soloway, MS 2010, 'Total prostatectomy within 6 weeks of a prostate biopsy: Is it safe?', International Braz J Urol, vol. 36, no. 2, pp. 177-181. https://doi.org/10.1590/S1677-55382010000200007
Adiyat, Kishore T. ; Manoharan, Murugesan ; Katkoori, Devendar ; Eldefrawy, Ahmed ; Soloway, Mark S. / Total prostatectomy within 6 weeks of a prostate biopsy : Is it safe?. In: International Braz J Urol. 2010 ; Vol. 36, No. 2. pp. 177-181.
@article{dc957168e31448e288bb4355c247ab8f,
title = "Total prostatectomy within 6 weeks of a prostate biopsy: Is it safe?",
abstract = "Purpose: Many urologists recommend a six-week time interval between a prostate biopsy and a total prostatectomy (TP) to allow the biopsy induced inflammation to subside. Our aim was to assess whether the time interval between prostate biopsy and TP has an impact on the surgical outcome. Materials and Methods: A retrospective analysis was performed on data from patients who underwent a TP by a single surgeon from 1992 to 2008. The patients were divided into two groups according to the time interval between biopsy and TP, Group 1 ≤ 6 weeks and Group 2 > 6 weeks. Relevant perioperative variables and outcome were analyzed. Results: 923 patients were included. There was a significant difference between the two groups in the surgeons' ability to perform a bilateral nerve sparing procedure. Those who had a TP within six weeks of the biopsy were less likely to have a bilateral nerve sparing procedure. No significant difference was noted in the other variables, which included Gleason score, surgical margin status, estimated blood loss, post-operative infection, incontinence, erectile function, and biochemical recurrence. Conclusions: TP can be safely performed without any increase in complications within 6 weeks of a prostate biopsy. However, a TP within six weeks of a biopsy significantly reduced the surgeon's perception of whether a bilateral nerve sparing procedure was performed.",
keywords = "Biopsy, Outcomes, Prostatectomy, Prostatic neoplasms",
author = "Adiyat, {Kishore T.} and Murugesan Manoharan and Devendar Katkoori and Ahmed Eldefrawy and Soloway, {Mark S.}",
year = "2010",
month = "3",
day = "1",
doi = "10.1590/S1677-55382010000200007",
language = "English",
volume = "36",
pages = "177--181",
journal = "International braz j urol : official journal of the Brazilian Society of Urology",
issn = "1677-5538",
publisher = "Brazilian Society of Urology",
number = "2",

}

TY - JOUR

T1 - Total prostatectomy within 6 weeks of a prostate biopsy

T2 - Is it safe?

AU - Adiyat, Kishore T.

AU - Manoharan, Murugesan

AU - Katkoori, Devendar

AU - Eldefrawy, Ahmed

AU - Soloway, Mark S.

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Purpose: Many urologists recommend a six-week time interval between a prostate biopsy and a total prostatectomy (TP) to allow the biopsy induced inflammation to subside. Our aim was to assess whether the time interval between prostate biopsy and TP has an impact on the surgical outcome. Materials and Methods: A retrospective analysis was performed on data from patients who underwent a TP by a single surgeon from 1992 to 2008. The patients were divided into two groups according to the time interval between biopsy and TP, Group 1 ≤ 6 weeks and Group 2 > 6 weeks. Relevant perioperative variables and outcome were analyzed. Results: 923 patients were included. There was a significant difference between the two groups in the surgeons' ability to perform a bilateral nerve sparing procedure. Those who had a TP within six weeks of the biopsy were less likely to have a bilateral nerve sparing procedure. No significant difference was noted in the other variables, which included Gleason score, surgical margin status, estimated blood loss, post-operative infection, incontinence, erectile function, and biochemical recurrence. Conclusions: TP can be safely performed without any increase in complications within 6 weeks of a prostate biopsy. However, a TP within six weeks of a biopsy significantly reduced the surgeon's perception of whether a bilateral nerve sparing procedure was performed.

AB - Purpose: Many urologists recommend a six-week time interval between a prostate biopsy and a total prostatectomy (TP) to allow the biopsy induced inflammation to subside. Our aim was to assess whether the time interval between prostate biopsy and TP has an impact on the surgical outcome. Materials and Methods: A retrospective analysis was performed on data from patients who underwent a TP by a single surgeon from 1992 to 2008. The patients were divided into two groups according to the time interval between biopsy and TP, Group 1 ≤ 6 weeks and Group 2 > 6 weeks. Relevant perioperative variables and outcome were analyzed. Results: 923 patients were included. There was a significant difference between the two groups in the surgeons' ability to perform a bilateral nerve sparing procedure. Those who had a TP within six weeks of the biopsy were less likely to have a bilateral nerve sparing procedure. No significant difference was noted in the other variables, which included Gleason score, surgical margin status, estimated blood loss, post-operative infection, incontinence, erectile function, and biochemical recurrence. Conclusions: TP can be safely performed without any increase in complications within 6 weeks of a prostate biopsy. However, a TP within six weeks of a biopsy significantly reduced the surgeon's perception of whether a bilateral nerve sparing procedure was performed.

KW - Biopsy

KW - Outcomes

KW - Prostatectomy

KW - Prostatic neoplasms

UR - http://www.scopus.com/inward/record.url?scp=77953940110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953940110&partnerID=8YFLogxK

U2 - 10.1590/S1677-55382010000200007

DO - 10.1590/S1677-55382010000200007

M3 - Article

VL - 36

SP - 177

EP - 181

JO - International braz j urol : official journal of the Brazilian Society of Urology

JF - International braz j urol : official journal of the Brazilian Society of Urology

SN - 1677-5538

IS - 2

ER -